Gilead combo HIV pill matches Truvada efficacy but safer in trial

(Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news